<DOC>
	<DOCNO>NCT02922972</DOCNO>
	<brief_summary>The aim prospective study ass efficacy autologous Platelet Rich Plasma prepare RegenKit-BCT prevention treatment keloid scar refractory conventional treatment . Fifteen patient include received three PRP injection session one-month interval . The outcome assess baseline ( treatment ) , 3 , 6 , 12 24 month last injection session . Safety assess reported adverse event analysis .</brief_summary>
	<brief_title>Treatment Keloid Scar Autologous Platelet Rich Plasma Obtained With RgenKit-BCT</brief_title>
	<detailed_description />
	<mesh_term>Keloid</mesh_term>
	<criteria>Patients keloid scar refractory conventional treatment . The indication PRP injection base absence response corticosteroid alone combination surgery 4 session infiltration and/or absence response therapy . Patients young 18 year Pregnancy breastfeed Patients suffer anemia patient active skin disorder infection include active hepatitis human infection virus infection Autoimmune disease Hashimoto , rheumatoid arthritis . Malignancy without metastatic disease Chemotherapy Anticoagulant therapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Keloid scar</keyword>
	<keyword>Wound heal</keyword>
	<keyword>Platelet-Rich Plasma</keyword>
	<keyword>RegenLab</keyword>
</DOC>